Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses
- 31 July 2011
- journal article
- Published by Elsevier BV in Peptides
- Vol. 32 (7), 1518-1525
- https://doi.org/10.1016/j.peptides.2011.05.015
Abstract
No abstract availableKeywords
Funding Information
- NSFC (30471584, 30530140)
This publication has 37 references indexed in Scilit:
- Imcroporin, a New Cationic Antimicrobial Peptide from the Venom of the Scorpion Isometrus maculatesAntimicrobial Agents and Chemotherapy, 2009
- Transcriptome analysis of the venom gland of the scorpion Scorpiops jendeki: implication for the evolution of the scorpion venom arsenalBMC Genomics, 2009
- Inhibition of measles virus infections in cell cultures by peptide-conjugated morpholino oligomersVirus Research, 2009
- Mucroporin, the First Cationic Host Defense Peptide from the Venom ofLychas mucronatusAntimicrobial Agents and Chemotherapy, 2008
- Human β-Defensins Suppress Human Immunodeficiency Virus Infection: Potential Role in Mucosal ProtectionJournal of Virology, 2005
- Antiviral activity of antimicrobial cationic peptides against Junin virus and herpes simplex virusInternational Journal of Antimicrobial Agents, 2004
- Evaluation of the Inactivation of Infectious Herpes Simplex Virus by Host-Defense PeptidesEuropean Journal of Clinical Microbiology & Infectious Diseases, 2000
- Emerging and Re-emerging Infectious DiseasesJournal of Infection, 2000
- Emerging diseases: a global threatBiotechnology Advances, 1999
- Ribavirin and Intravenous Immune Globulin Therapy for Measles Pneumonia in HIV InfectionSouthern Medical Journal, 1993